Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
First Look: Fed Probe, Bank Cap Shock, Gold Soars, Deals
07:38am, Tuesday, 13'th Jan 2026
Stock News DOJ subpoenas Fed chair spark backlash: Federal prosecutors served grand jury subpoenas to Jerome Powell over testimony on Fed HQ renovations, prompt
Novo Nordisk CEO: Wegovy not only reduces your weight, but it also shows cardiovascular benefits
07:48pm, Monday, 12'th Jan 2026
Mike Doustdar, Novo Nordisk president and CEO, joins 'Mad Money' host Jim Cramer to talk the success of GLP-1, pricing for weight-loss pills and more.
Novo Nordisk CEO: People have been waiting for a GLP-1 pill
07:41pm, Monday, 12'th Jan 2026
Mike Doustdar, Novo Nordisk president and CEO, joins 'Mad Money' host Jim Cramer to talk the success of GLP-1, pricing for weight-loss pills and more.
Novo Nordisk sees oral pills capturing over third of GLP-1 market by 2030
03:52pm, Monday, 12'th Jan 2026
Oral weight-loss drugs could make up a third or more of the overall GLP-1 market by 2030, a larger percentage than the company originally anticipated, a Novo Nordisk executive said on Monday.
Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs
12:36pm, Monday, 12'th Jan 2026
Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of blockbuster GLP-1 drugs, underscoring how cheaper, unapproved alternatives
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 12'th Jan 2026
Novo Nordisk (NVO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novo Nordisk A/S $NVO Shares Sold by Commonwealth Equity Services LLC
03:19am, Sunday, 11'th Jan 2026
Commonwealth Equity Services LLC reduced its stake in shares of Novo Nordisk A/S (NYSE: NVO) by 49.9% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutio
2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market
08:00am, Saturday, 10'th Jan 2026
In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster inject
NEW: Wegovy launches first-ever once-daily weight loss pill
07:45pm, Friday, 09'th Jan 2026
Novo Nordisk executive vice president of U.S. operations Dave Moore discusses the drugmaker's newly launched once-daily oral weight-loss pill on ‘The Claman Countdown.'
Novo Nordisk and Eli Lilly can both gain GLP-1 market share this year, says Citi's Meacham
06:22pm, Friday, 09'th Jan 2026
Geoff Meacham, Citi analyst, joins 'Fast Money' to talk what the year ahead holds for competition in the obesity drug market.
Market Today: Meta taps nuclear; GM books $6B EV charge
05:35pm, Friday, 09'th Jan 2026
Stock News California billionaire tax splits tech leaders: Nvidia (NVDA) CEO Jensen Huang said he's âfineâ with a proposed one-time 5% California wealth tax
Amazon Pharmacy starts offering Novo Nordisk's Wegovy weight-loss pill
11:21am, Friday, 09'th Jan 2026
Amazon said it now offers Novo Nordisk's Wegovy weight-loss pill through its digital pharmacy service. Novo Nordisk began rolling out its first-ever GLP-1 pill in the U.S. earlier this week.
Amazon Adds Novo Nordisk's Wegovy Pill to Pharmacy Platform
10:34am, Friday, 09'th Jan 2026
Amazon Pharmacy (AMZN, Financials) stated that it is now selling Novo Nordisk's (NVO, Financials) Wegovy weight loss medication via both insurance programs and
Amazon Pharmacy offers Novo Nordisk's Wegovy pill
09:12am, Friday, 09'th Jan 2026
Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy pill through insurance plans as well as through a cash-pay option.
Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing
06:45pm, Thursday, 08'th Jan 2026
Novo Nordisk (NVO) concluded the recent trading session at $57.34, signifying a +1.36% move from its prior day's close.
